CN101181427A - Externally used medicament for curing scaly tetter - Google Patents

Externally used medicament for curing scaly tetter Download PDF

Info

Publication number
CN101181427A
CN101181427A CNA2007101144363A CN200710114436A CN101181427A CN 101181427 A CN101181427 A CN 101181427A CN A2007101144363 A CNA2007101144363 A CN A2007101144363A CN 200710114436 A CN200710114436 A CN 200710114436A CN 101181427 A CN101181427 A CN 101181427A
Authority
CN
China
Prior art keywords
radix
drug
curing
herba
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007101144363A
Other languages
Chinese (zh)
Other versions
CN101181427B (en
Inventor
布焕景
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007101144363A priority Critical patent/CN101181427B/en
Publication of CN101181427A publication Critical patent/CN101181427A/en
Application granted granted Critical
Publication of CN101181427B publication Critical patent/CN101181427B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a drug which cures psoriasis and is produced by the raw materials of swamp mahogany, radix paeoniae lactiflorae, tasselblower, daphne genkwa, breynia fruticosa, erigeren candensis, eurya chinensis, garter snake, radix-polygoni multiflori, ledeboruiella root, lightyellow sophora root and Chinese atractylodes herb medicine. The drug of the invention has the advantages that: the drug has no poisonous and side effect, no stimulating effect and hypersusceptibility reaction; the function is quick; the recrudescence does not easily occur; the curing charge is low, the drug resource is wide with cheap price; the effective rate of the drug of the invention curing psoriasis is 90 percent and the curing rate is 85 percent.

Description

Treat psoriasic external used medicine
Technical field
The invention belongs to pure technical field of Chinese medicines, the psoriasic external used medicine of a kind of specifically treatment.
Background technology
Psoriasis is many gives birth to dry, skin by wind, wet, heat three evil Yun resistance skins or nutrient QI and blood being insufficient, wind syndrome due to blood-deficiency and loses and support or direct stimulation. and many-sides such as trauma infection contamination cause, come to a conclusion but still has so far clearly.Psoriasis is a kind of common dermatomycosis, belongs to frequently-occurring disease, also is psoriasis, and modern medicine is neurodermatitis.Primary disease is mainly in extremity, cervical region, and many symmetries take place, and clinical show as is initially syringe needle or the big red pimple of the grain of rice more, dry and solid, surface-brightening, for a long time it, then integrated flat pimple increases pachyderma gradually, be dried to Xi Wenzhuan, desquamation is arranged, or pachyderma, the skin lesion flushing,, erosion, blood crusts, local desiccation, plumpness, desquamation, shape such as cattle skin, slight Pruritus is arranged.This obstinate dermatosis makes the patient taste varieties of misery, enjoys to decoct, torment, and has brought great misery to the patient.The modern medicine Therapeutic Method adopts more at present: aminopterin. ethyliminum. and bimolane. cell toxicant kind anti-cancer drugs and dexamethasone such as cyclophosphamide. the treatment of hormone medicines such as prednisone and the healthy and free from worry gram of import medicine, curative effect is not ideal enough, easily recurrence after the drug withdrawal, it is big that the normal phase of Western medicine is taken side effect, various ingredients have grievous injury to body and Liver and kidney and immunologic function, the medicine that has is only effective to the individual types in the psoriasis, and is not only invalid to other type, increases the weight of on the contrary after the use; Though have effective in cure but curative effect is slow, the course of treatment is long, and needing more than 1 year could produce effects, has brought great economic loss to the patient like this.The psoriasic Chinese medicine of some Chinese herbal treatments exists prescription not smart as Radix Rumicis Crispi diffusing (Yizong Jinjian),, do not have the psoriasic effect of treatment.
Summary of the invention
To sum up through clinical verification for many years, and it will be argued that and manyly give birth to dry, skin by wind, wet, heat three evil Yun resistance skins or nutrient QI and blood being insufficient, wind syndrome due to blood-deficiency and lose and support or direct stimulation. many-sides such as trauma infection contamination cause, become poison in nutrient blood loss, qi depression to blood stasis, the blood and cause psoriasis.Deficiency in the above-mentioned prior art curing psoriasis being existed the invention provides a kind of thoroughly medicine for radical treatment of psoriasis.
Technical scheme of the present invention is: a kind of antipsoriatics thing, it is to be made by the herbal raw material proportioning of following weight parts: Folium Eucalypti Robustae 12-20, Radix Paeoniae Alba 10-20, Herba Duchesneae Indicae 10-15, Flos Genkwa 10-20, Fruticose Breyniae Leaf and Twig 10-20, Herba Erigerontis Canadensis (Herba Conyzae Canadensis) 10-15, GANGCHA 10-15, Zaocys 10-15-3, Radix Polygoni Multiflori 10-30, Radix Saposhnikoviae 10-15, Radix Sophorae Flavescentis 15-30, Rhizoma Atractylodis 5-10.Medicine-feeding is added 600 ml waters boil 200 milliliters of medicinal liquids wipings of supernatant affected part altogether.
The present invention compared with prior art, medicine advantage of the present invention is 1: the supernatant of getting of getting that medicine-feeding endures is altogether wiped the affected part and get final product, and easy to use, the patient is easy to acceptance; 2: consumption is little, and only need wipe 3-4 time every day, and side effect is little, has no stimulation, do not have irritated reaction; 4: effect is rapid, and 7-15 days each course of treatment, can take effect a course of treatment; 5: curative effect is sure, adheres to using the general patient of medicine of the present invention all can cure through clinical verification for many years; 6: be difficult for recurrence, at the bottom of the medical expense, the medicine source is extensively inexpensive.
Medicine optimum amount of the present invention is: Folium Eucalypti Robustae 20, the Radix Paeoniae Alba 15, Herba Duchesneae Indicae 15, Flos Genkwa 15, Fruticose Breyniae Leaf and Twig 20, Herba Erigerontis Canadensis (Herba Conyzae Canadensis) 15, GANGCHA 15, Zaocys 15, Radix Polygoni Multiflori 30, Radix Saposhnikoviae 15, Radix Sophorae Flavescentis 30, Rhizoma Atractylodis 10.
Radix Polygoni Multiflori, Radix Paeoniae Alba invigorating the liver and kidney benefiting essence-blood in the side, nourish blood and cloudy, be mainly and strengthen reticuloendothelial system function and cellular immunization, can reverse the pathology of psoriasis to strengthen skin immune function controlling; Folium Eucalypti Robustae, Herba Duchesneae Indicae,, Flos Genkwa, Fruticose Breyniae Leaf and Twig, gather heat-clearing and toxic substances removing altogether, antipruritic, the parasite killing of drawing out pus by applying a plaster to the affected part is controlled skin ulcer; Herba Erigerontis Canadensis (Herba Conyzae Canadensis), Radix Sophorae Flavescentis, Radix Saposhnikoviae, Rhizoma Atractylodis, kill antipruritic, the dispelling wind for relieving itching of Ci, nourshing Yin and drynsessmoistening prescription; GANGCHA cooperates Folium Eucalypti Robustae, Herba Duchesneae Indicae, Radix Sophorae Flavescentis, Radix Saposhnikoviae enhancing heat-clearing and toxic substances removing, dispelling wind for relieving itching, parasite killing to control the effect of tinea; Freely play the flesh table with the Zaocys dispelling wind and removing obstruction in the collateral and resist evil poison, all medicines cooperate, and have heat-clearing and toxic substances removing, dispelling wind for relieving itching, nourish blood and function cloudy, that parasite killing is controlled tinea.Handbook is: middle hospital pharmacy, the Guangdong college of traditional Chinese medicine compile, the Guangdong People's Press publishes the first impression in June, 1973.
The specific embodiment:
Get medicine Folium Eucalypti Robustae 20 of the present invention, the Radix Paeoniae Alba 15, Herba Duchesneae Indicae 15, Flos Genkwa 15, Fruticose Breyniae Leaf and Twig 20, Herba Erigerontis Canadensis (Herba Conyzae Canadensis) 15, GANGCHA 15, Zaocys 15, Radix Polygoni Multiflori 30, Radix Saposhnikoviae 15, Radix Sophorae Flavescentis 30, Rhizoma Atractylodis 10.Getting after medicine-feeding adds 600 ml waters and endure altogether, getting supernatant and wipe the affected part for 200 milliliters, only need wipe 3-4 time every day, and 7-15 days each course of treatment, can take effect a course of treatment; Adhere to using the general patient of medicine of the present invention all can cure through clinical verification for many years; Evident in efficacy, be difficult for recurrence, have no side effect effective percentage 90%, cure rate 85%.
260 routine GP THs to treatment are observed, and divide conventional therapy group and test of cure group.
Criterion of therapeutical effect: with the sx is effectively, is recovery from illness with the transference cure.
Conventional group treatment 130 examples, effective percentage 65%, cure rate 45%.Responding time 15-20 days, healing time 10-24 month.
Test of cure group Drug therapy 130 examples of the present invention, effective percentage 90%, cure rate 85%.Responding time 2-7 days, healing time 2-4 month.
Example 1: the Yang Qingzhen in Yang Zhuan village, Shouzhang town, Yanggu County, Shandong Province, the woman, 36 years old, in May, 2005 went to a doctor in the clinic, and the patient tells to such an extent that psoriasis had 12 years, once obeys a lot of antipsoriatics things, does not all cure.Disease sees that it is sclerderm entirely that whole body has 45% skin, and has cut the squamous sclerderm and come off, and through making medicine of the present invention, wipe 3-4 every day, treat first course of treatment after, illing skin deliquescing, head, hands, body, the lower limb affected part sign that begins to show improvement; After treating second course of treatment, head, hands, lower limb affected part transference cure, treat the 3rd course of treatment after, illing skin takes a turn for the better gradually, has not had sclerderm, deliquescing, dark skin; After treating the 4th course of treatment, dark skin becomes the normal colour of skin, and not recurrence is followed up a case by regular visits to so far in recovery from illness.
Wu Youchang is closed in the south of a town, area just outside a city gate, Guan County, 2:2006 Hebei province in August, the man, and 55 years old, the main suit got psoriasis and had 20 years, once obeyed a lot of antipsoriatics things, did not all cure.Disease sees that it is sclerderm entirely that whole body has 54% skin, and has cut a large amount of squamous sclerderm and come off, through making medicine of the present invention,, wipe 3-4 every day, treat four courses of treatment after, recurrence is followed up a case by regular visits to so far in recovery from illness.

Claims (2)

1. antipsoriatics thing, it is characterized in that: it is to be made by the herbal raw material proportioning of following weight parts: Folium Eucalypti Robustae 12-20, Radix Paeoniae Alba 10-20, Herba Duchesneae Indicae 10-15, Flos Genkwa 10-20, Fruticose Breyniae Leaf and Twig 10-20, Herba Erigerontis Canadensis (Herba Conyzae Canadensis) 10-15, GANGCHA 10-15, Zaocys 10-15-3, Radix Polygoni Multiflori 10-30, Radix Saposhnikoviae 10-15, Radix Sophorae Flavescentis 15-30, Rhizoma Atractylodis 5-10.
2. a kind of antipsoriatics thing according to claim 1 is characterized in that: it is to be made by the herbal raw material proportioning of following weight parts: Folium Eucalypti Robustae 20, the Radix Paeoniae Alba 15, Herba Duchesneae Indicae 15, Flos Genkwa 15, Fruticose Breyniae Leaf and Twig 20, Herba Erigerontis Canadensis (Herba Conyzae Canadensis) 15, GANGCHA 15, Zaocys 15, Radix Polygoni Multiflori 30, Radix Saposhnikoviae 15, Radix Sophorae Flavescentis 30, Rhizoma Atractylodis 10.
CN2007101144363A 2007-11-21 2007-11-21 Externally used medicament for curing scaly tetter Expired - Fee Related CN101181427B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101144363A CN101181427B (en) 2007-11-21 2007-11-21 Externally used medicament for curing scaly tetter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101144363A CN101181427B (en) 2007-11-21 2007-11-21 Externally used medicament for curing scaly tetter

Publications (2)

Publication Number Publication Date
CN101181427A true CN101181427A (en) 2008-05-21
CN101181427B CN101181427B (en) 2010-11-10

Family

ID=39446939

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101144363A Expired - Fee Related CN101181427B (en) 2007-11-21 2007-11-21 Externally used medicament for curing scaly tetter

Country Status (1)

Country Link
CN (1) CN101181427B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102379928A (en) * 2010-11-23 2012-03-21 袁平 Medicinal liquor for treating skin diseases
JP2017501982A (en) * 2013-11-27 2017-01-19 ドナテッラ・パオリーノDonatella PAOLINO Daphne Laurera extract in the treatment of dermatoses
CN112704702A (en) * 2020-12-22 2021-04-27 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) Traditional Chinese medicine composition for treating scalp psoriasis and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100467049C (en) * 2005-12-22 2009-03-11 夏金陵 Heat clearing toxin resolving medicine for treating psora and its preparation method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102379928A (en) * 2010-11-23 2012-03-21 袁平 Medicinal liquor for treating skin diseases
JP2017501982A (en) * 2013-11-27 2017-01-19 ドナテッラ・パオリーノDonatella PAOLINO Daphne Laurera extract in the treatment of dermatoses
CN112704702A (en) * 2020-12-22 2021-04-27 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) Traditional Chinese medicine composition for treating scalp psoriasis and preparation method thereof

Also Published As

Publication number Publication date
CN101181427B (en) 2010-11-10

Similar Documents

Publication Publication Date Title
CN101041046A (en) Chinese traditional medicine compound took orally for treating morning diarrhea
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN101284114A (en) Medicine for treating rheumatism and rheumatoid disease
CN1332702C (en) Medicine for treating psoriasis
CN101181427B (en) Externally used medicament for curing scaly tetter
CN101167991B (en) Burn and scald treating ointment
CN102475868A (en) Anti-rheumatism medicinal liquor
CN101002848B (en) Medicine for treating recurrent uarthritis, and its preparing method
CN102579700A (en) Medicinal liquor for treating arthritis
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN101129697A (en) Orally taken traditional Chinese medicine composition for treating atrophic arthritis
CN101057922A (en) Traditional Chinese medicine preparation for treating vitiligo
CN101979036A (en) Medicinal liquor for treating rheumatic arthritis
CN100566741C (en) A kind of antipsoriatics thing
CN1559555A (en) Adhesive plaster for treating pain of shoulder
CN1269504C (en) Medicine for treating rheumatic and rheumatoid arthritis
CN1181837C (en) Medicine for curing burn and scald
CN102114199B (en) Traditional Chinese medicine for treating bone cancer
CN101983712A (en) Novel medicament for treating coronary heart disease
CN1305507C (en) Medicinal spirit for rheumatism
CN105106768A (en) Traditional Chinese medicine for treating bedsore
CN104383211A (en) Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy
CN101607060B (en) Traditional Chinese medicine for treating urination incontinence
CN102895468B (en) Traditional Chinese medicine (TCM) preparation for treating psoriasis and preparation method
CN111840400A (en) External dressing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101110

Termination date: 20101121